Product Name: ETFDH antibody, N-term
Applications: FACS, IHC-P, WB
Predicted Target Size:
Positive Controls:
Form Supplied: Liquid
Concentration: Batch dependent mg/ml (Please refer to the vial label for the specific concentration)
Purification: Protein A purified, followed by peptide affinity purification.
Full Name: electron-transferring-flavoprotein dehydrogenase
Background: Electron-transferring-flavoprotein dehydrogenase in the inner mitochondrial membrane accepts electrons from electron-transfer flavoprotein which is located in the mitochondrial matrix and reduces ubiquinone in the mitochondrial membrane. The protein is synthesized as a 67-kDa precursor which is targeted to mitochondria and processed in a single step to a 64-kDa mature form located in the mitochondrial membrane. Deficiency in electron-transferring-flavoprotein dehydrogenase have been demonstrated in some patients with type II glutaricacidemia. [provided by RefSeq]
Synonyms: ETF dehydrogenase, ETFubiquinone, ETFDH, Electron transfer flavoproteinubiquinone oxidoreductase, mitochondrial, ETF-QO, ETFQO, Electrontransferringflavoprotein dehydrogenase, Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial, ETF QO
Cellular Localization:
CAS NO: 1619903-54-6
Cabozantinib
Host: Rabbit
Clonality: Polyclonal
Isotype: IgG
Immunogen: KLH conjugated synthetic peptide between 32-61 amino acids from the N-terminal region of human ETFDH.
Antigen Species: Human
Species Reactivity: Human
Conjugation: Unconjugated
Storage Buffer: PBS, 0.09% sodium azide.
Storage Instruction: Keep as concentrated solution. For short-term storage, store at 4° C (up to 10 days). For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
Notes: For In vitro laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Specificity:
PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/17989730?dopt=Abstract
